Aging and arterial-cardiac interactions in the elderly

International Journal of Cardiology

Volumn 155, Issue 1, 2012, Pages 14-19

  Maruyama, Yoshiaki ^a  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Aging; Arterial cardiac interactions; Fibroblast; Stem cell; Telomere

Indexed keywords

ANGIOTENSIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE;

ARTERY; BLOOD PRESSURE; CALORIC RESTRICTION; CARDIOVASCULAR FUNCTION; CELL AGING; CELL FUNCTION; ENDOCARDIUM; FIBROBLAST; FUNCTIONAL MORPHOLOGY; GENE EXPRESSION; HEART; HEART MUSCLE CELL; HEART VENTRICLE REMODELING; HUMAN; INTRACELLULAR SIGNALING; MATRIX FIBROSIS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; SMOOTH MUSCLE FIBER; STEM CELL; TELOMERE; TISSUE INTERACTION; VASCULAR ENDOTHELIUM;

EID: 84859897329     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2011.01.087     Document Type: Review

References (76)

1. Lakatta EG, Levy D. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: part I: aging arteries: a "set up" for vascular disease. Circulation 2003;107:139-46.
2. Lakatta EG. Arterial and cardiac aging: Major shareholders in cardiovascular disease enterprises: Part III: cellular and molecular clues to heart and arterial aging. Circulation 2003;107:490-7.
3. Susic D, Frohlich ED. The aging hypertensive heart: a brief update. Nat Clin Pract Cardiovasc Med 2008;2:104-10.
4. Sata M, Saiura A, Kunisato A, et al. Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat Med 2002;8:403-9.
5. Minamino T, Komuro I. Vascular aging: insights from studies on cellular senescence, stem cell aging, and progeroid syndromes. Nat Clin Pract Cardiovasc Med 2008;5:637-48.
6. McCaffrey TA, Nicholson AC, Szabo PE, et al. Aging and arteriosclerosis: the increased proliferation of arterial smooth muscle cells isolated from old rats is associated with increased platelet-derived growth factor-like activity. J Exp Med 1988;167:163-74.
7. Dimmeler S, Leri A. Aging and disease as modifiers of efficacy of cell therapy. Circ Res 2008;102:1319-30.
8. Benetos A, Okuda K, Lajemi M, et al. Telomere length as an indicator of biological aging: the gender effect and relation with pulse pressure and pulse wave velocity. Hypertension 2001;37:381-5.
9. Bekaert S, De Meyer T, Rietzschel ER, et al. Telomere length and cardiovascular risk factors in a middle-aged population free of overt cardiovascular disease. Aging Cell 2007;6:639-47.
10. Benetos A, Gardner JP, Zureik M, et al. Short telomeres are associated with increased carotid atherosclerosis in hypertensive subjects. Hypertension 2004;43: 182-5.
11. Benetos A, Okuda K, Lajemi M, et al. Telomere length as an indicator of biological aging: the gender effect and relation with pulse pressure and pulse wave velocity. Hypertension 2001;37(part 2):381-5.
12. Vasan RS, Demissie S, Kimura M, et al. Association of leukocyte telomere length with circulating biomarkers of the renin-angiotensin-aldosterone system: The Framingham Heart Study. Circulation 2008;177(9):1138-44.
13. Chang E, Harley CB. Telomere length and replicative aging in human vascular tissues. Proc Natl Acad Sci USA 1995;92:11190-4.
14. Minamino T, Miyauchi H, Yoshida T, et al. Endothelial cell senescence in human atherosclerosis: role of telomere in endothelial dysfunction. Circulation 2002;105: 1541-4.
15. Serrano AL, Andres V. Telomeres and cardiovascular disease: does size matter? Circ Res 2004;94(5):575-84.
16. Takasaki I, Chobanian AV, Sarzani R, et al. Effect of hypertension on fibronectin expression in the rat aorta. J Biol Chem 1990;265:21935-9.
17. Crawford DC, Chobanian AV, Brecher P. Angiotensin II induces fibronectin expression associated with cardiac fibrosis in the rat. Circ Res 1994;74:727-39.
18. McCaffrey TA, Falcone DJ. Evidence for an age-related dysfunction in the antiproliferative response to transforming growth factor-beta in vascular smooth muscle cells. Mol Biol Cell 1993;4:315-22.
19. Reed MJ, Corsa AC, Kudravi SA, et al. A deficit in collagenase activity contributes to impaired migration of aged microvascular endothelial cells. J Cell Biochem 2000;77:116-26.
20. Smith AR, Visioli F, Frei B, Hagen TM. Age-related changes in endothelial nitric oxide synthase phosphorylation and nitric oxide dependent vasodilation: evidence for a novel mechanism involving sphingomyelinase and ceramideactivated phosphatase 2A. Aging Cell 2006;5(5):391-400.
21. Rivard A, Fabre JE, Silver M, et al. Age-dependent impairment of angiogenesis. Circulation 1999;99:111-20.
22. Chen J, Bridsky SV, Goligorsky DM, et al. Glycated collagen I induces premature senescence-like phenotypic changes in endothelial cells. Circ Res 2002;90: 1290-8.
23. Guo KK, Ren J. Cardiac overexpression of alcohol dehydrogenase (ADH) alleviates aging-associated cardiomyocyte contractile dysfunction: role of intracellular Ca2+ cycling proteins. Aging Cell 2006;5(3):259-65.
24. Qian HS, de Resende MM, Beausejour C, et al. Age-dependent acceleration of ischemic injury in endothelial nitric oxide synthase-deficient mice: potential role of impaired VEGF receptor 2 expression. J Cardiovasc Pharmacol 2006;47(4): 587-93.
25. Cernadas MR, Sanchez de Miguel L, Garcia-Duran M, et al. Expression of constitutive and inducible nitric oxide synthases in the vascular wall of young and aging rats. Circ Res 1998;83:279-86.
26. Orlandi A, Marcellini M, Spagnoli LG. Aging influences development and progression of early aortic atherosclerotic lesions in cholesterol-fed rabbits. Arterioscler Thromb Vasc Biol 2000;20:1123-36.
27. Bransford TL, Malik A, Florea N, Duprez D. Is there a parallel between endothelial and endocardial function? Circulation 2005;111(4):E50.
28. Michel JB, Heudes D, Michel O, et al. Effect of chronic ANG I-converting enzyme inhibition on aging processes: II: large arteries. Am J Physiol 1994;267:R124-35.
29. Blacher J, Safar ME. Large-artery stiffness, hypertension and cardiovascular risk in older patients. Nat Clin Pract Cardiovasc Med 2005;2(9):450-5.
30. Bokov AF, Lindsey ML, Khodr C, Sabia MR, Richardson A. Long-lived ames dwarf mice are resistant to chemical stressors. J Gerontol A Biol Sci Med Sci 2009;64A(8): 819-27.
31. van der Loo B, Labugger R, Aebischer CP, et al. Cardiovascular aging is associated with vitamin E increase. Circulation 2002;105(14):1635-8.
32. Ungvari Z, Parrado-Fernandez C, Csiszar A, de Cabo R. Mechanisms underlying caloric restriction and lifespan regulation: implications for vascular aging. Circ Res 2008;102(5):519-28.
33. Colotti C, Cavallini G, Vitale RL, et al. Effects of aging and anti-aging caloric restrictions on carbonyl and heat shock protein levels and expression. Biogerontology 2005;6(6):397-406.
34. Michos ED, Rice KM, Szklo M, et al. Factors associated with low levels of subclinical vascular disease in older adults: multi-Ethnic Study of Atherosclerosis. Prev Cardiol 2009;12(2):72-9.
35. Tanaka H, Dinenno FA, Monahan KD, DeSouza CA, Seals DR. Carotid artery wall hypertrophy with age is related to local systolic blood pressure in healthy men. Arterioscler Thromb Vasc Biol 2001;21(1):82-7.
36. Strom JA, VanAuker MD, Carabello BA. Effects of aging on the diagnostic assessment of valvular heart disease. Am J Geriatr Cardiol 2006;15(5):286-90.
37. Barasch E, Gottdiener JS, Aurigemma G, et al. Association between elevated fibrosis markers and heart failure in the elderly: the cardiovascular health study. Circ Heart Fail 2009;2(4):303-10.
38. Mazzaro L, Almasi SJ, Shandas R, Seals DR, Gates PE. Aortic input impedance increases with age in healthy men and women. Hypertension 2005;45(6):1101-6.
39. Moreau KL, Gavin KM, Plum AE, Seals DR. Ascorbic acid selectively improves large elastic artery compliance in postmenopausal women. Hypertension 2005;45(6): 1107-12.
40. Fraticelli A, Josephson R, Danziger R, et al. Morphological and contractile characteristics of rat cardiac myocytes from maturation to senescence. Am J Physiol 1989;257:H259-65.
41. Lakatta EG, Levy D. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: part II: the aging heart in health: links to heart disease. Circulation 2003;107:346-54.
42. Anversa P, Palackal T, Sonnenblick EH, et al. Myocyte cell loss and myocyte cellular hyperplasia in the hypertrophied aging rat heart. Circ Res 1990;67:871-85.
43. Lakatta EG. Cardiovascular aging research: the next horizons. J Am Geriatr Soc 1999;47:613-25.
44. Cigola E, Kastura J, Li B, et al. Angiotensin II activates programmed myocyte cell death in vitro. Exp Cell Res 1997;231:363-71.
45. Younes A, Boluyt MO, O'Neill L, et al. Age-associated increase in rat ventricular ANP gene expression correlates with cardiac hypertrophy. Am J Physiol 1995;38: H1003-8.
46. Caffrey JL, Boluyt MO, Younes A, et al. Aging, cardiac proenkephalin mRNA and enkephalin peptides in the Fisher 344 rat. J Mol Cell Cardiol 1994;26:701-11.
47. Nadal-Ginard B, Kajstura J, Leri A, Anversa P. Myocyte death, growth, and regeneration in cardiac hypertrophy and failure. Circ Res 2003;92(2):139-50.
48. Lehrke S, Mazhari R, Durand DJ, et al. Aging impairs the beneficial effect of granulocyte colony-stimulating factor and stem cell factor on post-myocardial infarction remodeling. Circ Res 2006;99(5):553-60.
49. Torella D, Rota M, Nurzynska D, et al. Cardiac stem cell and myocyte aging, heart failure, and insulin-like growth factor-1 overexpression. Circ Res 2004;94(4): 514-24.
50. Vasan RS, Demissie S, Kimura M, et al. Association of leukocyte telomere length with echocardiographic left ventricular mass: the Framingham Heart Study. Circulation 2009;120(13):1195-202.
51. Chimenti C, Kajstura J, Torella D, et al. Senescence and death of primitive cells and myocytes lead to premature cardiac aging and heart failure. Circ Res 2003;93(7): 604-13.
52. Li SY, Du M, Dolence EK, et al. Aging induces cardiac diastolic dysfunction, oxidative stress, accumulation of advanced glycation endproducts and protein modification. Aging Cell 2005;4(2):57-64.
53. Liu L, Zhu J, Glass PS, et al. Age-associated changes in cardiac gene expression after preconditioning. Anesthesiology 2009;111(5):1052-64.
54. Inuzuka Y, Okuda J, Kawashima T, et al. Suppression of phosphoinositide 3-kinase prevents cardiac aging in mice. Circulation 2009;120(17):1695-703.
55. Swinnen M, Vanhoutte D, Van Almen GC, et al. Absence of thrombospondin-2 causes age-related dilated cardiomyopathy. Circulation 2009;120(16):1585-97.
56. Paternostro G, Vignola C, Bartsch DU, Omens JH, McCulloch AD, Reed JC. Ageassociated cardiac dysfunction in drosophila melanogaster. Circ Res 2001;88(10): 1053-8.
57. Louhelainen M, Vahtola E, Forsten H, et al. Oral levosimendan prevents postinfarct heart failure and cardiac remodeling in diabetic Goto-Kakizaki rats. J Hypertens 2009;27(10):2094-107.
58. Li Q, Ren J. Aging. Influence of cardiac-specific overexpression of insulin-like growth factor 1 on lifespan and aging-associated changes in cardiac intracellular Ca2+ homeostasis, protein damage and apoptotic protein expression. Cell 2007;6(6):799-806.
59. Pugh KG, Wei JY. Clinical implications of physiological changes in the aging heart. Drugs Aging 2001;18(4):263-76.
60. Fang CX, Doser TA, Yang X, Sreejayan N, Ren J. Metallothionein antagonizes aginginduced cardiac contractile dysfunction: role of PTP1B, insulin receptor tyrosine phosphorylation and Akt. Aging Cell 2006;5(2):177-85.
61. Dai DF, Santana LF, Vermulst M, et al. Overexpression of catalase targeted to mitochondria attenuates murine cardiac aging. Circulation 2009;119(21): 2789-97.
62. van der Loo B, Bachschmid M, Labugger R, et al. Expression and activity patterns of nitric oxide synthases and antioxidant enzymes reveal a substantial heterogeneity between cardiac and vascular aging in the rat. Biogerontology 2005;6(5):325-34.
63. Zieman SJ, Gerstenblith G, Lakatta EG, et al. Upregulation of the nitric oxide-cGMP pathway in aged myocardium: physiological response to l-arginine. Circ Res 2001;88(1):97-102.
64. Svanborg A. Age-related changes in cardiac physiology: Can they be postponed or treated by drugs? Drugs Aging 1997;10(6):463-72.
65. Izzo Jr JL. Aging and systolic hypertension: cluster patterns and problem-solving strategies to answer the genetic riddle. Hypertension 2001;37(4):1067-8.
66. Gates PE, Gentile CL, Seals DR, Christou DD. Adiposity contributes to differences in left ventricular structure and diastolic function with age in healthy men. J Clin Endocrinol Metab 2003;88(10):4884-90.
67. Saupe KW, Sobol SC, Koh SG, Apstein CS. Effects of AT1 receptor block begun late in life on normal cardiac aging in rats. J Cardiovasc Pharmacol 2003;42(4):573-80.
68. Abel ED. Glucose for the aging heart? Circulation 2007;116(8):884-7.
69. Linford NJ, Beyer RP, Gollahon K, et al. Transcriptional response to aging and caloric restriction in heart and adipose tissue. Aging Cell 2007;6(5):673-88.
70. Burlew BS, Weber KT. Cardiac fibrosis as a cause of diastolic dysfunction. Herz 2002;27:92-8.
71. Zamaneh K, Rama K. Myocardial extra-cellular matrix and regulation by metalloproteinases and their inhibitors. Thromb Haemost 2005;93:212-9.
72. Asakura M, Kitakaze M, Takashima S, et al. Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: metalloproteinase inhibitors as a new therapy. Nat Med 2002;8:35-40.
73. Khan R, Sheppard R. Fibrosis in heart disease: understanding the role of transforming growth factor-β1 in cardiomyopathy, valvular disease and arrhythmia. Immunology 2006;118:10-24.
74. Kupfahl C, Pink D, Friedrich K, et al. Angiotensin II directoly increases transforming growth factor β1 and osteopontin and indirectly affects collagen mRNA expression in the human heart. Cardiovasc Res 2000;46:463-75.
75. Maruyama Y. Aging-related arterial-cardiac interaction in Japanese men. Heart Vessels 2009;24:406-12.
76. Shewan LG and Coats AJ. Ethics in the authorship and publishing of scientific articles. Int J Cardiol 2010;144:1-2.